Author response to Letter to the Editor 'Liver impairment associated with disease progression in COVID-19 patients'.
作者信息
Zhang Yafei, Liu Lan, Zhao Qiu
机构信息
Department of Gastroenterology, Zhongnan Hospital of Wuhan University, Wuhan, China.
Clinical Center and Key Lab of Intestinal and Colorectal Diseases of Hubei Province, Wuhan, China.
出版信息
Liver Int. 2020 Jul;40(7):1791. doi: 10.1111/liv.14497. Epub 2020 May 13.
Abstract
摘要
相似文献
1
Author response to Letter to the Editor 'Liver impairment associated with disease progression in COVID-19 patients'.作者对致编辑的信《COVID-19患者疾病进展相关的肝功能损害》的回复
Liver Int. 2020 Jul;40(7):1791. doi: 10.1111/liv.14497. Epub 2020 May 13.
2
Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor.肺动脉血栓形成作为新型冠状病毒肺炎肺部疾病的重要并发症：致编辑的信
Virchows Arch. 2020 Sep;477(3):467-468. doi: 10.1007/s00428-020-02896-4.
3
Portal Vein Thrombosis in a Patient With COVID-19.一名新冠肺炎患者的门静脉血栓形成
Am J Gastroenterol. 2020 Sep;115(9):1545-1546. doi: 10.14309/ajg.0000000000000781.
4
Inferior mesenteric vein thrombosis and COVID-19.肠系膜下静脉血栓形成与新型冠状病毒肺炎
Rev Soc Bras Med Trop. 2020 Sep 21;53:e20200412. doi: 10.1590/0037-8682-0412-2020. eCollection 2020.
5
Reply to: Correspondence relating to "SARS-CoV-2 infection of the liver directly contributes to hepatic impairment in patients with COVID-19".回复：与“严重急性呼吸综合征冠状病毒2感染肝脏直接导致新型冠状病毒肺炎患者肝功能损害”相关的通信
J Hepatol. 2020 Oct;73(4):996-998. doi: 10.1016/j.jhep.2020.06.028. Epub 2020 Jun 23.
6
Pooled prevalence of deep vein thrombosis among coronavirus disease 2019 patients.2019冠状病毒病患者深静脉血栓形成的合并患病率。
Crit Care. 2020 Jul 28;24(1):466. doi: 10.1186/s13054-020-03181-1.
7
Response to Letter to the editor: Lung Ultrasound in COVID-19 Patients - More Shadows Than Information - Letter to the Editor on the Article "W. LU et al. Ultraschall in Med. 2020 Apr 15".致编辑的信的回复：COVID-19患者的肺部超声——阴影多于信息——致编辑的信，关于文章“W. LU等人，《医学超声》，2020年4月15日”
Ultraschall Med. 2020 Aug;41(4):441-442. doi: 10.1055/a-1184-4807. Epub 2020 Jun 25.
8
In Reply to the Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community".致编辑的信的回复，主题为“冠状病毒病（COVID-19）的神经学影响：神经科学界的实际考量” 。
World Neurosurg. 2020 Oct;142:535-536. doi: 10.1016/j.wneu.2020.06.115. Epub 2020 Jun 23.
9
Letter to the Editor: Coronavirus Disease 2019 (COVID-19), Infectivity, and the Incubation Period.致编辑的信：2019冠状病毒病（COVID-19）、传染性与潜伏期
J Prev Med Public Health. 2020 Mar;53(2):70. doi: 10.3961/jpmph.20.065. Epub 2020 Mar 31.
10
Letter in response to letter to the editor by Singh and Dhibar regarding the article "COVID-19: From bench to bedside" (Singh et al.).对辛格和迪巴尔就文章《COVID-19：从实验室到临床》（辛格等人著）致编辑的信的回复信。
Diabetes Metab Syndr. 2020 Sep-Oct;14(5):865. doi: 10.1016/j.dsx.2020.06.012. Epub 2020 Jun 12.
本文引用的文献
1
[The protocol for prevention, diagnosis and treatment of liver injury in coronavirus disease 2019].[新型冠状病毒肺炎肝损伤防治专家共识]
Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 20;28(3):217-221. doi: 10.3760/cma.j.cn501113-20200309-00095.
2
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在 COVID-19 患者中的诊断及预测作用。
Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504. Epub 2020 Apr 13.
3
The pattern and significance of abnormal liver function tests in community-acquired pneumonia.社区获得性肺炎患者肝功能检查异常的模式及意义
Eur J Intern Med. 2004 Nov;15(7):436-440. doi: 10.1016/j.ejim.2004.06.011.
Zotero 插件